University home page

Find an ExpertProfiling the University of Melbourne's Researchers

PROF DAVID COPOLOV



Contact Details

Organization: Psychiatry
Position: Honorary (Professorial Fellow)
Email:

Qualifications, Honours, Fellowships and Other Awards

Qualifications

Title Institution Date Awarded Abbreviation
Bachelor of Science Institution not known
Bachelor of Medicine Institution not known
Doctor of Philosophy Institution not known

Fellowships

Fellowship Date Awarded
Fellow of the Royal Australasian College of Physicians (FRACP)
Fellow of the Royal Australian and New Zealand College of Psychiatrists (FRANZCP)

Government Research Classifications

Research Fields, Courses and Discipline Classifications

Socio-Economic Objective Classifications

Grants and Contracts

Research Grants, Contracts and Consultancies awarded to the University of Melbourne as the administering institution (since 2003) as recorded in Themis Agreements.

Grants

Title Role Funding Source Scheme Award Date
Efficacy of treatment for resistant command hallucinations. Chief Investigator NHMRC Project Grants 01/01/2003

Publications

Publications produced at the University of Melbourne and reported in the Annual Publications Collection and 'Research Report' since 2001. The Themis Publications module, released in November 2006, allows additional publications from previous institutions and publications from past years to be entered.

Publications in 2008

Book Chapters

  • Management of negative symptoms
    Year: 2008
    Book: Pharmacological and psychosocial treatments in schizophrenia
    Publisher: Informa Healthcare
    Authors(s):
    Editors(s):

Journal Articles

  • Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and P50 suppression measures of sensorimotor and sensory gating in humans


    Year: 2008
    Journal: Neuropsychopharmacology
    Volume: 33
    Page numbers: 1653-1666
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

  • Glutathione precursor, N-Acetyl-Cysteine, Improves mismatch negativity in Schizophrenia patients


    Year: 2008
    Journal: Neuropsychopharmacology
    Volume: 33
    Page numbers: 2187-2199
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Acting on harmful command hallucinations in psychotic disorders: an integrative approach
    Year: 2008
    Journal: Journal of Nervous and Mental Disease
    Volume: 196
    Issue: 5
    Page numbers: 390-398
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • N-acetyl Cysteine as a Glutatione Precursor for Schizophrenia - A Double-Blind, Randomized, Placebo-Controlled Trial
    Year: 2008
    Journal: Biological Psychiatry
    Volume: 64
    Page numbers: 361-368
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • N-acetyl Cysteine for depressive symptoms in Bipolar Disorder - A Double-Blind, Randomized, Placebo-Controlled Trial
    Year: 2008
    Journal: Biological Psychiatry
    Volume: 64
    Page numbers: 468-475
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility
    Year: 2008
    Journal: Expert Opinion on Biological Therapy
    Volume: 8
    Issue: 12
    Page numbers: 1955-1962
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2007

Journal Articles

  • Olfactory sensitivity through the course of psychosis: Relationships to olfactory identification, symptomatology and the schizophrenia odour
    Year: 2007
    Journal: Psychiatry Research
    Volume: 149
    Issue: 2007
    Page numbers: 97-104
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2005

Journal Articles

  • Clozapine decreases [3H]CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens
    Year: 2005
    Journal: Naunyn-Schmiedebergs Archives of Pharmacology
    Volume: 371
    Issue: 5
    Page numbers: 428-433
    Publisher: Springer Verlag(New York)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Diseases of white matter and schizophrenia-like psychosis
    Year: 2005
    Journal: Australian and New Zealand Journal of Psychiatry
    Volume: 39
    Page numbers: 746-756
    Publisher: Blackwell Science Asia(Carlton)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2003

Books

  • Pharmacological and psychosocial treatments in schizophrenia
    Year: 2003
    Publisher: Martin Dunitz(London)
    Authors(s):

Book Chapters

  • Management of negative symptoms
    Year: 2003
    Book: Pharmacological and Psychosocial Treatments in Schizophrenia
    Publisher: Martin Dunitz(London)
    Authors(s):

Journal Articles

  • Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia
    Year: 2003
    Journal: Biological Psychiatry
    Volume: 53
    Page numbers: 585-592
    Publisher: Elsevier Science(New York)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia
    Year: 2003
    Journal: American Journal of Psychiatry
    Volume: 160
    Page numbers: 1790-1794
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow
    Year: 2003
    Journal: The Pharmacogenomics Journal
    Volume: 3
    Issue: 4
    Page numbers: 227-234
    Publisher: Nature Publishing Group
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder
    Year: 2003
    Journal: Journal of Affective Disorders
    Volume: 75
    Issue: 1
    Page numbers: 65-69
    Publisher: Elsevier Science
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2001

Book Chapters

  • Biological Therapies
    Year: 2001
    Book: Foundations of clinical psychiatry.
    Publisher: Melbourne University Press(Carlton)
    Authors(s):
  • Biopsychosocial factors in health and illness
    Year: 2001
    Book: Psychology and psychiatryIntegrating medical practice
    Publisher: John Wiley & Sons(West Sussex)
    Authors(s):

Journal Articles

  • A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia
    Year: 2001
    Journal: Schizophrenia Research
    Volume: 52
    Page numbers: 37-46
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Selective bilateral hippocampal volume loss in chronic schizophrenia
    Year: 2001
    Journal: Biological Psychiatry
    Volume: 50
    Page numbers: 531-539
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
    Year: 2001
    Journal: Neuroscience
    Volume: 103
    Issue: 1
    Page numbers: 9-15
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
top of page